Jüppner, Butz, Casaretto, Zahn and Hesch: Characterization of two anti-human parathyrin antisera 175 J. Clin. Chem. Clin. Biochem. Vol. 20,1982, pp. 175-180 Characterization of Two Anti-Human Parathyrin Antisera (Received July 14/December 7,1981) Summary: Two anti-human parathyrin antisera were raised in sheep. These were characterized by radioimmunoassay using two commercially available bovine parathyrin preparations and one synthetic human parathyrin fragment (sequence 42-55 (42-Tyr)) for radioiodination. In addition, four synthetic human parathyrin fragments (sequences 1-34, 32-43, 44-68, 53^84), one bovine parathyrin peptide (sequence 28-48) and a human parathyrin Standard from a tissue culture contaiiiing the intact hormpne were utilized in a competitive Inhibition assay against the two radiolabelled bovine parathyrin preparations. On column chromatography, both tracers revealed a diffefence in molecular weight, which is believed to be related to the extraction technique. The sequence fragment 44-68 of human parathyrin had the highest affinity for the two antisera when using the srnäller molecular weight tracer and there were no qualitative changes observed in the presence of plasma. Using the higher molecular weight tracer, the addition of plasma to one of the antisera resulted in a higher affinity for the sequence fragment 1-34 of human parathyrin cömpared tö that of intact parathyrin. Antiserum frpm a second sheep remained specific only for the mid-region (sequence 44-r68) of the parathyrin molecüle independent of the tracer used. Due to the antiserum's constant characteristic, it revealed a high reliability for the discrimination between plasma parathyrin levels in normal probands and in patients with hyperparathyroidism. Our data demonstrate that the specificity of the radioimmunoassay for human parathyrin is not exclusively dependent the antibody spurce, but also on the tracer preparation and the protein content of the incubation medium. 
Introduction
Critical Interpretation of radioimmunochemical determinations of human parathyrin requires knowledge of the specificity of the antibody for various parathyrin fragments. Three factors contribute to difficulties in the Interpretation of parathyrin levels: a) the heterogeneity of the antisera which have been produced(l), b) the source of the labelled tracer and c) the heterogeneity of circulating human parathyrin fragments (l, 2).
These circulating C-regional and mid-regional parathyrin fragments are generated to a considerable extent by peripheral cleavage of the intact parathyrin in the sequence region 33-42 (3) . This suggests that the secretion rate of the intact parathyrin, which in itself has an extremely short half-life (4) may best be monitored by C-regional breakdown peptides with a prolonged circulation in plasma. Therefore, in clinical use, antibodies with a high affinity for these portions of parathyrin have been most useful for discriminating between normal and diseased Status (5, 6, 7) . Two commercially availäble preparations of bovine parathyrin used in this study for radioiodination have been shown to elute differently on gel-filtration, thus exposing different antigenic sites for antibody interactions and thereby altering the assay specificity (8) . Our studies were performed to further characterize two anti-parathyrin-antisera and to deflne the most constant antibody for parathyrin determinations in plasma.
Materials and Methods

Antisera
Two sheep (G III and C III) were immunized with approximateiy 200 Mg human parathyrin which was extracted äs described (9) with trichloroacetic acid from human parathyroid adenomas. After Chromatographie purification the hormone was düuted in distilled water to a final concentration of approximately 100 mg/1 and was subsequently emulsifled with an equal amount of complete Freund's adjuvant (BehringrWerke, Marb ürg/Lahn, FRG). Two milliliters pf the mixture were injected intradermally at 15-20 sites on the backs of the animals. Each animal received a booster injection after 3 weeks and then again after 6 weeks. Three weeks after each booster, the sheep were bled and the anti-parathyrin titer was tested in the radioimmunoassay. For studies including the bovine parathyrin tracers the antisera were used in a final dilution of 1/26250 (G III), and 1/5250 or 1/8700 (C III). For the experiments üsing the sequence fragment 42-55 (42-Tyr) of human parathyrin äs a tracer, both antisera were used in a final dilution of 1/1750. lodination of bovine parathyrin Two preparations of highly purified bovine parathyrin were used for this investigation: i) Lot no. 156552 from Wilson, Chicago, USA n) Lot no. 1515Cool from Inolex, Chicago, USA Both hormones were iodinated with 12S I (specific activity 296-555 GBq/mg (8-15 Ci/mg) NaI) by a modification of the method of Hunter & Greenwood (10, 11) . 5 Mg bovine parathyrin were incubated for 20 seconds with 18.5 MBq (0.5 mCi) of Na 12S I and 25 Mg Chloramine T in a final volume of 30 .
(Chloramine T and rnetabisulphite were dissolved, and hormone and Na 12S I were diluted in 50 mmol/1 phosphate buffer, pH 7.6). The reaction was stopped by adding 50 of a solution containing 60 Mg rnetabisulphite. The mixture was immediately transfered to a diy cellulose column (0.4 X 3.5 cm) (cellulose: Whatman CF l). The free iodine was eluted with a buffer containing 0.025 rnpl/1 Na-barbital, 0.004 mol/1 Na-acetate, 0.0045 mol/1 NaO and 0.1 g/l Merthiölate, pH 7.4 (buffer A). To remove the partially purified radiolabelled f hormone from the cellulose, the column was eluted with normal serum. the two peak fractions were further purified on -Gel P10 (2.5 X 30 cm), equilibrated and eluted with 0.1 mol/1 ammonium acetate buffei, pH 4:5. The second major peak of each hormone preparation was used for the radioimmunoassay. * . . . lodination ofthe sequence fragment 42^55 (42-Tyr) o f human parathyrin This peptide was radioiodinated according to the protocol for labelling the bovine parathyrin pfeparations, except that the Separation öf the labelled hormone and the free iodine was performed on Sephadex (MO (0.9 X 18 cm).
Standards
The follbwing Standards were used: i) Tissue culture Standard (P2 Hamburg) was described in more detail elsewhefe (12) . By means of various biologicäl assays (the adenylate cyclase assay using human and bovine renal plasma membraries, the cytochemical assay and the labeüed-antibödy-membrane-assay (LAMA)), this Standard was shpwn to contain approximately 126 Mg/11-84 human parathyrin. ilowever, wheii using antiserum G111 and Inolex tracer to cömpare the P2 parathyrin concentratioft with the 1-84 human parathyriri stand* ard 75/549 (from thVNational Institute of Biologicäl Standard and Control, Mill Hill, London), a 1-84 human parathyrin concentratipn 100 MgA P2 was calculated. These data indicäte that this material eontains not exclüsiveiy the intact hormone, but also other parathyrin peptides with a higher affinity for antibody G III. ii) Synthetic fragments of human parathyrin include the 1^=34, 44--6S, 32-43 and the 53-84 regiori of the hormone.
iii) The synthetic 28-48 fragment of bovine parathyrin. Human parathyrin sequences l -34, 44-68, 53-84 and bovine parathyrin sequence 24-48, synthesized by the solid phase methodj were obtained from M. Rosenbtytt, Boston, USA (13) . The homogeneity of the peptides was pröved by high perfoirnance liquid chromatography. Human parathyrin sequences 32-43 and 42-55 (42-Tyr) were liquid syiithesized by ff. Zahn and M. Casäretto, aiid homogeneity was proved by ion-exchange chromatography. The amino acid connpösition of each peptide, determined after acid hydrolysis, confirmed the predicted amino acid ratios. The lyophyüzed peptides were dissolved in acetic acid (0.01 mol/1) and were stored in aliquots at -20 °C. Each Standard curve point was performed in duplicate.
Radioimmunoassay
The assay was performed äs describecl by Hehrmann et al. (5, 11) . The final volume of 350 M! consisted of 50 M! Standard, 100 M! parathyrin tracer (approx. 5000 counts/min) and 200 M! antibody. The tracer and the antibody were diluted in buffer B (buffer A confaining 10 g/l human serum albumin, from Behring-Werke, Nlarburg/Lahn, FRG). The Standards were either dissolved in the same buffer or in charcoal treated normal serum (5, 11) . The Standard and the antibody were preincubated for 18-24 h at 4 °C, until the tracer was added for another 48 h at 4 °C. Bouiid and free hormone were separated by the addition of 2 ml of ice cold Dextran^coated charcoal. This was prepared by mixing l g Dextran T 70 (Pharmacia, Uppsala, Sweden) and 10g Norit A charcoal (Serva, Heidelberg, FRG) suspended in 400 ml of buffer A cpntainiiig 25 g/l human serum albumin. After 10 minutes of incubation at 4 °C, the tubes were eentrifuged for 15 minutes at 2800 g at 4 °C. The bound and >the free hormone were counted for radioactivity in an äutomatic gamma counter (Berthold, Wildbad, ^RG). Data is expressed äs J. CÜn. Chefii. Clin. Biochem. l Vol. 20,1982 / No. 4 B/B (binding of the sample over maximal binding in the absence of cold hormone). Non-speciftc binding, which was determined in a separate control tube without the addition of antibody, is expressed s the fraction of radioactivity in the supernatant after oharcoal Separation compared to the total radioactivity. B 0 was calculated by dividing the difference in the number of counts of the bound and non-specific binding by the total counts added. The tubes for non-specific binding and maximal binding (B ) were incubated either with the addition of buffer B or charcoal treated plasma, depending on the medium used for diluting the Standards.
Results
The effect of synthetic fragmenfs on the binding oflnolex tracer to CIII antiserwn
The specificity of the antiserum C III using the Inolex material s tracer was only minimally affected by the presence of parathyrin-free plasma. As shown in figure l a, Standards dissolved in buffer B displaced 0.50 of the tracer at 0.046 nmol/1 of the 44-68 human parathyrin fragment. As shown in figure Ib the same displacement was observed at 0.11 nmol/1 when the peptide was dissolved in charcoal-treated plasma. Using the .intact parathyrin (P2) 0.50 displacement was reached at P2 content of 80 and 100 μΐ/ΐ, respectively. The 53-84 fragment of human parathyrin displaced maximally at 0.35 of the tracer while the 1-34 human, 28-48 bovine and the 32-43 human parathyrin had no influence on the tracer-antibody binding. 
The effect of synthetic fragments on the binding ofthe Wilson tracer to CIII antiserum
Using the Wilson preparation, entirely different results were obtained. As shown in figure Ic, dilution ofthe Standards in parathyrin-free plasma decreased the sensitivity of the assay for the intact human parathyrin. Even at the highest Standard concentration, only 0.35 ofthe tracer was displaced. Interestingly, 0.31 nmol/1 1-34 human parathyrin displaced the tracer to the same extent indicating a high affinity of the antibody for this fragment. Sequence fragments 28-48 of bovine para-
Effect of synthetic fragments on the binding of Inolex and Wilson tracer to GIII antiserum
Using Wilson or Inolex tracer, the addition of plasma to GIII assays had no effect ön the specificity of the systein. Therefore, this immunoserum was tested with the two tracer preparations using Standards dissolved only in buffer B. As depicted in figures 2a and 2b, there were no qualitative changes with either tracer used for the experiments. Similar to antibody CIII, the 44-68 human paräthyrin ftagment had the highest affiiiity for the antibody. The protein concentration (Standard dissolved either in buffer B or in parathyrin^free plasma) did not alter the antibody specificity. Only in higher molar concentrations did the other fragments displace the tracer. A slight decrease in sensitivity was öbserved for the 44-=68 human parathyriii frägment when using the Inolex tracer. However, the overall reactivity was essentially similar compared with the Standard curves dissolved in plasma.
Binding of radiolabetted sequence 42-^55 (42-Tyr) of human parathyrin to antibody G111 and CHI
Bpth antibodies were used in a final düution of 1/1750. Only 0.033 (C ) and 0.012 (G III) respectively, of the total radioactivity were boünd specifically tö the antir body. Non-specific binding was O.Öl l in this experiment.
Geljntration ofthe Wilson and the Inolex tracer
It is likely that the fäilure of the Iriolex tracer to detect the N-regiön ofthe parathyrin molecule might be due to a lack of constituents of the 1-34 region. Therefore, the Chromatographie elution patterns of both träcers were compared ( fig. 3) . The Inolex tracer elutes from the Bio-Gel P10 column at a läter position than the Wilson material. This alreädy indicates th'at the Inolex material may have a lower molecular weight than the Wilson material. Another investigator using the same Inolex 60 70 Fig. 3 . The two tracer preparations used in this study were repurified on -Gel P10 after an initial partial purification on a cellulose column. The second major peak of radioactivity of each tracer preparation was used for the radioimmunoassays.
Discussion
The radioimmunochemical determination of human parathyrin is still plagued by significant difficulties. Our data iUustrates that the assay specificity is dependent upon at least three different components: the antibody source, the tracer preparation and the incubation milieu. Similar to some antisera described recently (5, 6, 8) , both of our newly raised antibodies have the highest affinity for the mid-region of the parathyrin molecule (sequence 44-68) when using a mid-regional tracer. GIII was already shown to be extremely useful in the discrimination between normal and eleväted parathyrin plasma levels due to primary and secondary hyperpära-thyroidisiii (7). Antiserum CIII, being more difficult to characterize, has not been used for extensive studies thus far. Our results suggest that the specificity of this antibody is dramatically affected by the choice of the tracer preparation. Using the C-regional oriented tracer (Inolex), C III is most sensitive for the 44-68 peptide. However, with the intact tracer (Wilson), the assay becomes sensitive for the N-terminal peptide -34. Whether this change of specificity is related to confqrmational changes of the peptide induced by plasma pro t ein, or is a result of decreased adsorption of the peptide to the surface of the incubation tubes (15) is unclear. This observation makes it likely that antiserum CIII contains two distinctly different anti-parathyrinimmunoglobulins; one being anti-mid-regional (protein independent) the other being anti-N*terminal (protein dependent) with a relatively Ipw titer. This wouM explain the decrease in maximal specific binding when performed in buffer. Most of the C III antkparathyrinimmunoglobulin reacts preferentially with protions of the Inolex tracer (C-regional); therefore a high maximal binding is obtained at a final antibody dilution of 1/8700. In contrast, when the assay was performed with the Wilson tracer, B 0 decreased at a final antibody dilution of 1/5200, thus illustrating a protein-dependent binding to the N-terminal antibody portions. Additional experiments using a tyrosinated 1-34 (34-Tyr) human parathyrin tracer (unpublished data) showed a maximal specifie binding of 0.264 at a final dilution of 1/1750. These observations make it very likely that antiserum CIII consists of at least two antibody idiotypes. Antibody G III remained specific for the C-regional parathyrin independent of the tracer, which makes it very useful for clinical studies. However, slight changes in sensitivity due to the tracer were observed. Our data illustrates that the assay specificity is also related to the protein content in the incubation mixture. Using the Wilson tracer, the characteristics of antiserum C III were influenced by plasma addition. Specific maximal binding increased more than twofold, while the non-specific binding remained nearly unchanged. Thi § implies that plasma fractions facilitate the binding of the N-regional oriented tracer to the antibody. The mechanism of this reaction, however, is unknown but seems to be restricted to N-terminal oriented or intact tracers. In contrast, the C-regional specific tracer exhibited no vulnerability to changes in plasma content, which has also been reported by other investigators (16) . However, plasma seems not only to facilitate the binding of the N-terminal tracer to the antibody, but also that of N-terminal peptides, since the 1-34 peptide revealed a higher ability to displace the Wilson tracer. Whether these changes in affinity, for either the tracer or the Standard, are related to changes in reactivity of the immunoglobulins, or to conformational effects on the tracer hormones is unknown. Changes in the conformation may be responsible for the inabiüty of the iodinated sequence 42-55 (42-Tyr) of human parathyrin to bind to both antibodies. This was astonishing äs this peptide covers most of the 44-68 human parathyrin sequence. The 28-48 bovine parathyrin and the 53-84 human parathyrin (both including parts of the 44-68 sequence) are almost unable to displace either of the tracer preparations. Therefore, distinct conformational requirements for peptide-antibody interactions are to be expected. Similar observations have already been described for the 1-12 fragment of human parathyrin (17) , thus confirming this explanation. No explanation can yet be offered for the increased npn-specific binding of the Wilson tracer. However, the träcer binding to plasma components should be considered (18) . This also would imply that only N-terminal parts of the parathyrin molecule have a high affinity for plasma fractions, while mid-and C-regional fragments are only weakly attached to proteins (16) .
Conclusion
Our findings demonstrate that antibody G III is very useful for the determination of C-and mid-regional parathyrin Fragments containing the sequence 44-68, independent of the tracer preparation and the protein content of the assay System. Antibody C III is an interesting antiserum, which could be used under welldefined incubation conditions for the detection of N-terminal and intact parathyrin. Parathyrin from tissue culture is shown to be extremly useful for routine parathyrin radioimmunoassays and might provide better interlaboratpry comparison than pqoled hyperparathyroid sera, since this hormone preparation can be produced in large quantities. ' f
